Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and Its Relevance to Atherosclerosis
Emmanuel L. Gautier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
被撤回的出版物: CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice (Retracted article. See vol. 177, pg. 555, 2014)
J. Li et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Plerixafor In Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma
Antona J. Wagstaff
DRUGS (2009)
Chemokine receptor antagonists: part 2
James E. Pease et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
Chemokine receptor antagonists: Part 1
James E. Pease et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
An Engineered GM-CSF-CCL2 Fusokine Is a Potent Inhibitor of CCR2-Driven Inflammation As Demonstrated in a Murine Model of Inflammatory Arthritis
Moutih Rafei et al.
JOURNAL OF IMMUNOLOGY (2009)
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice
Daniel Eefting et al.
JOURNAL OF VASCULAR SURGERY (2009)
Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
Joshua S. Hunt et al.
PHARMACOTHERAPY (2009)
Safety concerns about CCR5 as an antiviral target
Amalio Telenti
CURRENT OPINION IN HIV AND AIDS (2009)
Monocyte-mediated defense against microbial pathogens
Natalya V. Serbina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Chemokines and their receptors: Drug targets in immunity and inflammation
Antonella Viola et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Modulation of CCR2 in rheumatoid arthritis - A double-blind, randomized, placebo-controlled clinical trial
Clarissa E. Vergunst et al.
ARTHRITIS AND RHEUMATISM (2008)
Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice
Christophe Combadiere et al.
CIRCULATION (2008)
Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis
Shiva Shahrara et al.
JOURNAL OF IMMUNOLOGY (2008)
Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection
Gabriel T. Schnickel et al.
JOURNAL OF IMMUNOLOGY (2008)
A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis
Elin Kindberg et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile Virus infection: A meta-analysis of 4 cohorts in the US epidemic
Jean K. Lim et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Inhibition of MCP-1/CCR2 Signaling Does Not Inhibit Intimal Proliferation in a Mouse Aortic Transplant Model
Jeffrey D. Alexis et al.
JOURNAL OF VASCULAR RESEARCH (2008)
Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting Stents attenuates in-stent stenosis in rabbits and monkeys
Kensuke Egashira et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice
Regina Krohn et al.
CIRCULATION (2007)
Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients
Taiji Nozaki et al.
JOURNAL OF IMMUNOLOGY (2007)
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys
Kaku Nakano et al.
ATHEROSCLEROSIS (2007)
Targeting of Gr-l+,CCR2+ monocytes in collagen-induced arthritis
Hilke Bruehl et al.
ARTHRITIS AND RHEUMATISM (2007)
CCR5 blockade modulates inflammation and alloimmunity in primates
Carsten Schroeder et al.
JOURNAL OF IMMUNOLOGY (2007)
CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis
Maureen N. Ajuebor et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation
Hideki Tatewaki et al.
JOURNAL OF VASCULAR SURGERY (2007)
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival
L. Yang et al.
TRANSPLANTATION PROCEEDINGS (2007)
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells
W. I. Khan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo
A. Schepers et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice
Stephane Potteaux et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
CCR5 antagonists: the answer to inflammatory disease?
Traci L. Ness et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
CC chemokine receptor (CCR)-2 prevents arthritis development following infection by Mycobacterium avium
Marlon P. Quinones et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10
Alma Zernecke et al.
BLOOD (2006)
Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis:: a meta-analysis
S Prahalad
GENES AND IMMUNITY (2006)
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2
NV Serbina et al.
NATURE IMMUNOLOGY (2006)
Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis
Isabel J. Crane et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
CCR5 deficiency increases risk of symptomatic West Nile virus infection
WG Glass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis
S. Prahalad et al.
GENES AND IMMUNITY (2006)
HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice
EJA van Wanrooij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection
JW Tyner et al.
NATURE MEDICINE (2005)
Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection
WG Glass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
CM Brodmerkel et al.
JOURNAL OF IMMUNOLOGY (2005)
A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection
S Akashi et al.
TRANSPLANTATION (2005)
Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo
NR Veillard et al.
CIRCULATION (2005)
The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis
H Tokuyama et al.
INTERNATIONAL IMMUNOLOGY (2005)
Decreased IgG production but increased MIP-1β expression in collagen-induced arthritis in C-C chemokine receptor 5-deficient mice
L Bao et al.
CYTOKINE (2005)
Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells
MN Ajuebor et al.
JOURNAL OF IMMUNOLOGY (2005)
Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts
H Amano et al.
JOURNAL OF IMMUNOLOGY (2005)
Local cytokine environments drive aneurysm formation in allografted aortas
K Shimizu et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development
J Guo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis
V Pokorny et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells
Y Oba et al.
EXPERIMENTAL HEMATOLOGY (2005)
Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5
MPM Vierboom et al.
ARTHRITIS AND RHEUMATISM (2005)
Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis
MP Quinones et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice
WH Ni et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection
JJ Yun et al.
CIRCULATION (2004)
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice
NR Veillard et al.
CIRCULATION RESEARCH (2004)
Differential role of CCR2 in islet and heart allograft rejection: Tissue specificity of chemokine/chemokine receptor function in vivo
R Abdi et al.
JOURNAL OF IMMUNOLOGY (2004)
Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells
H Brühl et al.
JOURNAL OF IMMUNOLOGY (2004)
Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys
K Ohtani et al.
GENE THERAPY (2004)
Differential expression of chemokines and chemokine receptors in murine islet allografts: The role of CCR2 and CCR5 signaling pathways
B Schroppel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets
A Schober et al.
CIRCULATION RESEARCH (2004)
Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy
A Saiura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism
I Lee et al.
JOURNAL OF IMMUNOLOGY (2003)
The role of the beta chemokines in experimental obliterative bronchiolitis
AS Farivar et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2003)
Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3
Y Chvatchko et al.
JOURNAL OF IMMUNOLOGY (2003)
MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury
WJH Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
TN/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection
NV Serbina et al.
IMMUNITY (2003)
Blood monocytes consist of two principal subsets with distinct migratory properties
F Geissmann et al.
IMMUNITY (2003)
C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse
MN Ajuebor et al.
JOURNAL OF IMMUNOLOGY (2003)
Propagermanium suppresses macrophage-mediated formation of coronary arteriosclerotic lesions in pigs in vivo
H Shimokawa et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
WA Kuziel et al.
ATHEROSCLEROSIS (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
The unique target specificity of a nonpeptide chemokine receptor antagonist: selective blockade of two Th1 chemokine receptors CCR5 and CXCR3
P Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Long-term, treatment with propagermanium suppresses atherosclerosis in WHHL rabbits
Y Eto et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice
S Inoue et al.
CIRCULATION (2002)
Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys
M Usui et al.
FASEB JOURNAL (2002)
Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury
A Schober et al.
CIRCULATION (2002)
The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection
R Abdi et al.
DIABETES (2002)
Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits
E Mori et al.
CIRCULATION (2002)
Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys
K Egashira et al.
CIRCULATION RESEARCH (2002)
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration
T Yamashita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature
PM Murphy
PHARMACOLOGICAL REVIEWS (2002)
Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse
DM Dambach et al.
HEPATOLOGY (2002)
CCR2 deficiency decreases intimal hyperplasia after arterial injury
M Roque et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates - Inhibitory potential depends on type of injury and leukocytes targeted
C Horvath et al.
CIRCULATION RESEARCH (2002)
The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium
YQ Huo et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Beneficial effects of targeting CCR5 in allograft recipients
W Gao et al.
TRANSPLANTATION (2001)
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
JA Belperio et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
CC chemokine receptor 5 and renal-transplant survival
M Fischereder et al.
LANCET (2001)
An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2
S Yokochi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice
M Mack et al.
JOURNAL OF IMMUNOLOGY (2001)
C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis
S Youssef et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis:: Lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine
PG Andres et al.
JOURNAL OF IMMUNOLOGY (2000)
CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis
I Zapico et al.
GENES AND IMMUNITY (2000)
Human vascular smooth muscle cells possess functional CCR5
AD Schecter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
